The importance of Molecular Monitoring in CML
Susan Branford, University of Adelaide, Australia
Please click on the image below to watch the webcast, and a window will open. You can then also click on the slides to jump to certain sections of the presentation. Please share your feedback below, and view the other Virtual Education Program modules.
|
|
Issues covered
- Measurement of BCR-ABL transcript levels to assess residual disease
- Recommended monitoring for CML
- The significance of achieving a major molecular response
|
Has this been helpful? Please provide your comments here:
Facteur de variabilité de la réponse au ITK</li>
<li>Les trois grand mécanismes de résistance</li>
<li>La réponse au traitement</li>
<li>Autres inhibiteurs de tyrosine kinase: le Nilotinib et le Dasatinib